Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?

Aizawa H, Karasaki T, Nagayama K, Shinozaki-Ushiku A, Aburatani H, Mano H, Nakajima J.

Intern Med. 2020 Feb 12. doi: 10.2169/internalmedicine.3682-19. [Epub ahead of print]

2.

[Reexpansion Pulmonary Edema and Atrial Fibrillation after Resection of a Giant Solitary Fibrous Tumor of the Pleura].

Kitano K, Shinohara Y, Ikemura M, Karasaki T, Nagayama K, Sato M, Anraku M, Nakajima J.

Kyobu Geka. 2019 Nov;72(12):997-1000. Japanese.

PMID:
31701910
3.

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.

Ohue Y, Kurose K, Karasaki T, Isobe M, Yamaoka T, Futami J, Irei I, Masuda T, Fukuda M, Kinoshita A, Matsushita H, Shimizu K, Nakata M, Hattori N, Yamaguchi H, Fukuda M, Nozawa R, Kakimi K, Oka M.

J Thorac Oncol. 2019 Dec;14(12):2071-2083. doi: 10.1016/j.jtho.2019.08.008. Epub 2019 Aug 23.

4.

Impact of Previous Malignancy on Outcome in Surgically Resected Non-Small Cell Lung Cancer.

Nakao K, Anraku M, Karasaki T, Kitano K, Nagayama K, Sato M, Nakajima J.

Ann Thorac Surg. 2019 Dec;108(6):1671-1677. doi: 10.1016/j.athoracsur.2019.06.074. Epub 2019 Aug 14.

PMID:
31421101
5.

Differences Between Patients With Idiopathic Pleuroparenchymal Fibroelastosis and Those With Other Types of Idiopathic Interstitial Pneumonia in Candidates for Lung Transplants.

Shiiya H, Tian D, Sato M, Karasaki T, Kitano K, Nagayama K, Anraku M, Kaga K, Matsui Y, Nakajima J.

Transplant Proc. 2019 Jul - Aug;51(6):2014-2021. doi: 10.1016/j.transproceed.2019.04.035. Epub 2019 Jul 11.

PMID:
31303415
6.

Use of electromagnetic navigation bronchoscopy in virtual-assisted lung mapping: the effect of on-site adjustment.

Sato M, Shinohara Y, Yanagiya M, Karasaki T, Kitano K, Nagayama K, Nakajima J.

Gen Thorac Cardiovasc Surg. 2019 Dec;67(12):1062-1069. doi: 10.1007/s11748-019-01137-z. Epub 2019 May 16.

PMID:
31098868
7.

Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.

Nejo T, Matsushita H, Karasaki T, Nomura M, Saito K, Tanaka S, Takayanagi S, Hana T, Takahashi S, Kitagawa Y, Koike T, Kobayashi Y, Nagae G, Yamamoto S, Ueda H, Tatsuno K, Narita Y, Nagane M, Ueki K, Nishikawa R, Aburatani H, Mukasa A, Saito N, Kakimi K.

Cancer Immunol Res. 2019 Jul;7(7):1148-1161. doi: 10.1158/2326-6066.CIR-18-0599. Epub 2019 May 14.

PMID:
31088845
8.

Competing Risk Analysis in Lung Cancer Patients Over 80 Years Old Undergoing Surgery.

Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, Furuhata Y, Kashiwabara K, Ichinose J, Kawashima M, Nakajima J.

World J Surg. 2019 Jul;43(7):1857-1866. doi: 10.1007/s00268-019-04982-4.

PMID:
30937488
9.

Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.

Sun C, Anraku M, Karasaki T, Kuwano H, Nagayama K, Nitadori JI, Sato M, Nakajima J.

Eur J Cardiothorac Surg. 2019 Mar 1;55(3):414-420. doi: 10.1093/ejcts/ezy324.

PMID:
30289481
10.

High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma.

Karasaki T, Qiang G, Anraku M, Sun Y, Shinozaki-Ushiku A, Sato E, Kashiwabara K, Nagayama K, Nitadori JI, Sato M, Murakawa T, Kakimi K, Fukayama M, Nakajima J.

J Thorac Dis. 2018 Aug;10(8):4741-4750. doi: 10.21037/jtd.2018.07.45.

11.

Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years.

Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, Furuhata Y, Ichinose J, Kawashima M, Nakajima J.

Eur J Cardiothorac Surg. 2018 May 1;53(5):980-986. doi: 10.1093/ejcts/ezx437.

PMID:
29272371
12.

NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer.

Hoshikawa M, Aoki T, Matsushita H, Karasaki T, Hosoi A, Odaira K, Fujieda N, Kobayashi Y, Kambara K, Ohara O, Arita J, Hasegawa K, Kakimi K, Kokudo N.

Biochem Biophys Res Commun. 2018 Jan 8;495(2):2058-2065. doi: 10.1016/j.bbrc.2017.12.083. Epub 2017 Dec 15.

PMID:
29253566
13.

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.

Matsushita H, Hasegawa K, Oda K, Yamamoto S, Nishijima A, Imai Y, Asada K, Ikeda Y, Karasaki T, Fujiwara K, Aburatani H, Kakimi K.

Oncoimmunology. 2017 Jun 16;6(8):e1338996. doi: 10.1080/2162402X.2017.1338996. eCollection 2017.

14.

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.

Karasaki T, Nagayama K, Kuwano H, Nitadori JI, Sato M, Anraku M, Hosoi A, Matsushita H, Morishita Y, Kashiwabara K, Takazawa M, Ohara O, Kakimi K, Nakajima J.

J Thorac Oncol. 2017 May;12(5):791-803. doi: 10.1016/j.jtho.2017.01.005. Epub 2017 Jan 11.

15.

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.

Karasaki T, Nagayama K, Kuwano H, Nitadori JI, Sato M, Anraku M, Hosoi A, Matsushita H, Takazawa M, Ohara O, Nakajima J, Kakimi K.

Cancer Sci. 2017 Feb;108(2):170-177. doi: 10.1111/cas.13131. Epub 2017 Feb 9.

16.

[Neoantigens and Whole-Exome Sequencing].

Karasaki T, Nakajima J, Kakimi K.

Gan To Kagaku Ryoho. 2016 Jul;43(7):791-7. Review. Japanese.

PMID:
27431622
17.

Advances in personalized cancer immunotherapy.

Kakimi K, Karasaki T, Matsushita H, Sugie T.

Breast Cancer. 2017 Jan;24(1):16-24. doi: 10.1007/s12282-016-0688-1. Epub 2016 Mar 21. Review.

PMID:
27000871
18.

Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.

Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.

Cancer Immunol Res. 2016 May;4(5):463-71. doi: 10.1158/2326-6066.CIR-15-0225. Epub 2016 Mar 15.

19.

Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer.

Karasaki T, Nagayama K, Kawashima M, Hiyama N, Murayama T, Kuwano H, Nitadori J, Anraku M, Sato M, Miyai M, Hosoi A, Matsushita H, Kikugawa S, Matoba R, Ohara O, Kakimi K, Nakajima J.

J Thorac Oncol. 2016 Mar;11(3):324-33. doi: 10.1016/j.jtho.2015.11.006. Epub 2015 Dec 29.

20.

Life-Threatening Postpneumonectomy Syndrome Complicated with Right Aortic Arch after Left Pneumonectomy.

Karasaki T, Tanaka M.

Case Rep Surg. 2015;2015:768067. doi: 10.1155/2015/768067. Epub 2015 May 28.

21.

Opsoclonus-myoclonus syndrome associated with non-small cell lung cancer.

Karasaki T, Tanaka M.

Asian Cardiovasc Thorac Ann. 2015 Nov;23(9):1113-5. doi: 10.1177/0218492315587994. Epub 2015 Jun 1.

PMID:
26038602
22.

Imaging of thoracic duct in a patient with right-sided descending aorta.

Karasaki T, Tanaka M.

Ann Thorac Surg. 2015 Feb;99(2):713. doi: 10.1016/j.athoracsur.2014.10.019. No abstract available.

PMID:
25639420
23.

New onset of myasthenia gravis 10 years after proton beam therapy for thymoma.

Karasaki T, Murakawa T, Nagayama K, Nitadori J, Anraku M, Kikuchi Y, Shinozaki-Ushiku A, Igaki H, Nakajima J.

Gen Thorac Cardiovasc Surg. 2016 May;64(5):290-3. doi: 10.1007/s11748-014-0484-9. Epub 2014 Oct 10.

PMID:
25301055
24.

Outcomes of outpatient treatment for primary spontaneous pneumothorax using a small-bore portable thoracic drainage device.

Karasaki T, Shintomi S, Nomura Y, Tanaka N, Saito H, Yoshida Y.

Thorac Cardiovasc Surg. 2014 Sep;62(6):516-20. doi: 10.1055/s-0034-1374650. Epub 2014 May 29.

PMID:
24875808
25.

Invasive thymoma disseminated into the pleural cavity: mid-term results of surgical resection.

Murakawa T, Karasaki T, Kitano K, Nagayama K, Nitadori J, Anraku M, Nakajima J.

Eur J Cardiothorac Surg. 2015 Mar;47(3):567-72. doi: 10.1093/ejcts/ezu210. Epub 2014 May 19.

PMID:
24842578
26.

Sciatic hernia: is it really rare?

Karasaki T, Nakagawa T, Tanaka N.

Surg Today. 2014 Jun;44(6):1079-83.

PMID:
24078001
27.

Long-term outcomes after obturator hernia repair: retrospective analysis of 80 operations at a single institution.

Karasaki T, Nomura Y, Tanaka N.

Hernia. 2014 Jun;18(3):393-7. doi: 10.1007/s10029-013-1159-7. Epub 2013 Sep 24.

PMID:
24062142
28.

Beware of gossypibomas.

Karasaki T, Nomura Y, Nakagawa T, Tanaka N.

BMJ Case Rep. 2013 Jun 21;2013. pii: bcr2013010059. doi: 10.1136/bcr-2013-010059.

29.

Obturator hernia: the relationship between anatomical classification and the Howship-Romberg sign.

Karasaki T, Nakagawa T, Tanaka N.

Hernia. 2014 Jun;18(3):413-6. doi: 10.1007/s10029-013-1068-9. Epub 2013 Mar 13.

PMID:
23483264
30.

Obturator hernia of the fallopian tube.

Karasaki T, Nakagawa T, Tanaka N.

Abdom Imaging. 2013 Jun;38(3):619-21. doi: 10.1007/s00261-012-9962-7.

PMID:
22990633
31.

Complete resection of unresectable liver metastases from colorectal cancer without deterioration of liver function after cetuximab and irinotecan: two case reports.

Karasaki T, Sano K, Takamoto T, Kinoshita H, Tateishi R, Takemura T, Makuuchi M.

Hepatogastroenterology. 2010 Nov-Dec;57(104):1526-8.

PMID:
21443115
32.

Video-assisted thoracic surgery lobectomy preserves more latissimus dorsi muscle than conventional surgery.

Karasaki T, Nakajima J, Murakawa T, Fukami T, Yoshida Y, Kusakabe M, Ohtsu H, Takamoto S.

Interact Cardiovasc Thorac Surg. 2009 Mar;8(3):316-9; discussion 319-20. doi: 10.1510/icvts.2008.193672. Epub 2008 Dec 5.

PMID:
19059949
33.

[The biological property of polyene antibiotic].

KARASAKI T.

Yakugaku Kenkyu. 1961 May 25;33:294-308. Japanese. No abstract available.

PMID:
13751422
34.

Studies on the blood concentration of trichomycin. VI. The therapeutic blood concentration for experimental candidiasis in the rabbit.

KARASAKI T.

Antibiot Chemother (Northfield). 1959 Jun;9(6):337-48. No abstract available.

PMID:
24545265
35.

Studies on the blood concentration of trichomycin. V. Blood concentration following oral administration of trichomycin.

KARASAKI T, WATANABE N, KUMADA S.

Antibiot Chemother (Northfield). 1958 Apr;8(4):180-6. No abstract available.

PMID:
24544720
36.
37.
38.

Studies on the blood concentration of trichomycin. II. Application of the turbidimetric method to blood samples.

KARASAKI T.

Antibiot Chemother (Northfield). 1957 May;7(5):218-26. No abstract available.

PMID:
24544420
39.

Studies on the blood concentration of trichomycin. I. Turbidimetric microdetermination of trichomycin.

KARASAKI T.

Antibiot Chemother (Northfield). 1957 May;7(5):209-17. No abstract available.

PMID:
24544419

Supplemental Content

Loading ...
Support Center